Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zinc Supplementation in Children With Sickle Cell Disease
NCT03293641Completed
- Sponsor
- Victoria Biomedical Research Institute
- Start
- May 2016
- Primary completion
- Jan 2017
01
Overview
Randomised, open-label trial (2 arms), sponsored by Victoria Biomedical Research Institute. Primary endpoint: Measurement of change in zinc levels from baseline at study conclusion at 6 months. Started May 2016; status: completed.
Beyond the preview
Go deeper on NCT03293641.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03293641.